DexCom (DXCM) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.98 -0.23%
EPS Growth %: +27.1%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: +27.1%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million.
GUIDANCE:
DexCom sees Q3 2022 revenue of $2.86-2.91 billion, versus the consensus of $2.92 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- Gorilla Technology raises Q2 2026 revenue outlook to $44M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
